Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- PMID: 27639843
- DOI: 10.1016/j.jhep.2016.08.023
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
Abstract
Background & aims: Exercise is a first-line therapy for patients with non-alcoholic fatty liver disease (NAFLD). We sought to: 1) summarize effective aerobic and resistance exercise protocols for NAFLD; and 2) compare the effects and energy consumption of aerobic and resistance exercises.
Methods: A literature search was performed using PubMed, Web of Science, and Scopas to January 28, 2016. From a total of 95 articles, 23 studies including 24 aerobic and 7 resistance exercise protocols were selected for the summary of exercise protocols. Twelve articles including 13 aerobic and 4 resistance exercise protocols were selected for the comparative analysis.
Results: For aerobic exercise, the median effective protocol was 4.8 metabolic equivalents (METs) for 40min/session, 3times/week for 12weeks. For resistance exercise, the median effective protocol was 3.5 METs for 45min/session, 3times/week for 12weeks. Aerobic and resistance exercise improved hepatic steatosis. No significant difference was seen in the duration, frequency, or period of exercise between the two exercise groups; however, %VO2max and energy consumption were significantly lower in the resistance than in the aerobic group (50% [45-98] vs. 28% [28-28], p=0.0034; 11,064 [6394-21,087] vs. 6470 [4104-12,310] kcal/total period, p=0.0475).
Conclusions: Resistance exercise improves NAFLD with less energy consumption. Thus, resistance exercise may be more feasible than aerobic exercise for NAFLD patients with poor cardiorespiratory fitness or for those who cannot tolerate or participate in aerobic exercise. These data may indicate a possible link between resistance exercise and lipid metabolism in the liver.
Lay summary: Both aerobic and resistance exercise reduce hepatic steatosis in non-alcoholic fatty liver disease (NAFLD) with similar frequency, duration, and period of exercise (40-45min/session 3times/week for 12weeks); however, the two forms of exercise have different characteristics. Intensity and energy consumption were significantly lower for resistance than for aerobic exercise. Resistance exercise may be more feasible than aerobic exercise for NAFLD patients with poor cardiorespiratory fitness or for those who cannot tolerate or participate in aerobic exercise.
Keywords: Adipokine; Aerobic training; Exercise energy consumption; Myokine; Resistance training.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
[Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].Zhonghua Gan Zang Bing Za Zhi. 2018 Jan 20;26(1):34-41. doi: 10.3760/cma.j.issn.1007-3418.2018.01.009. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 29804360 Clinical Trial. Chinese.
-
Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.Clin Transl Gastroenterol. 2021 Mar;12(3):e00316. doi: 10.14309/ctg.0000000000000316. Clin Transl Gastroenterol. 2021. PMID: 33939383 Free PMC article. Clinical Trial.
-
The benefits of exercise for patients with non-alcoholic fatty liver disease.Expert Rev Gastroenterol Hepatol. 2015;9(10):1247-50. doi: 10.1586/17474124.2015.1075392. Epub 2015 Aug 4. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26289101 Review.
-
Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.World J Gastroenterol. 2016 Jul 21;22(27):6318-27. doi: 10.3748/wjg.v22.i27.6318. World J Gastroenterol. 2016. PMID: 27468220 Free PMC article. Review.
-
Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.Front Endocrinol (Lausanne). 2022 Nov 3;13:1032164. doi: 10.3389/fendo.2022.1032164. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36407307 Free PMC article.
Cited by
-
A journey of a thousand miles begins with one small step.Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):112-114. doi: 10.21037/hbsn-23-612. Epub 2024 Jan 16. Hepatobiliary Surg Nutr. 2024. PMID: 38322218 Free PMC article. No abstract available.
-
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease.Antioxidants (Basel). 2024 Jan 10;13(1):87. doi: 10.3390/antiox13010087. Antioxidants (Basel). 2024. PMID: 38247511 Free PMC article. Review.
-
Aerobic exercise promotes the expression of ATGL and attenuates inflammation to improve hepatic steatosis via lncRNA SRA.Sci Rep. 2022 Mar 30;12(1):5370. doi: 10.1038/s41598-022-09174-0. Sci Rep. 2022. PMID: 35354841 Free PMC article.
-
Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.J Clin Exp Hepatol. 2019 Jul-Aug;9(4):491-496. doi: 10.1016/j.jceh.2019.01.007. Epub 2019 Feb 7. J Clin Exp Hepatol. 2019. PMID: 31516265 Free PMC article. Review.
-
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.Lancet Gastroenterol Hepatol. 2022 Aug;7(8):755-769. doi: 10.1016/S2468-1253(22)00061-9. Epub 2022 Apr 28. Lancet Gastroenterol Hepatol. 2022. PMID: 35490698 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical